Press Release:Press Information Bureau
- Classification:Chemical Auxiliary Agent, Chemical Auxiliary Agent
- cas no 117-84-0
- Other Names:DOP Bis(2-ethylhexyl) phthalate
- MF:C24H38O4, C24H38O4
- EINECS No.:201-557-4
- Purity:99.5% min.
- Type:Plastizer
- Usage:Rubber Auxiliary Agents
- MOQ:200kgs
- Package:200kgs/battle
- Advantage:Stable
- Payment:T/T
Department of Pharmaceuticals (DoP) notified the amended Schedule-I of Drugs Prices Control Order (DPCO) 2013 on 11 th November 2022 based on National List of
Dr. Mansukh Mandaviya stated this while appreciating the efforts of the applicants selected under the scheme. The Department of Pharmaceuticals (DoP) has released the first
India’s new promotion code for medical devices Key
- Classification:Chemical Auxiliary Agent
- CAS No.:117-84-0
- Other Names:DiOctyle Phthalate DOP
- MF:C24H38O4
- EINECS No.:201-557-4
- Purity:99.5
- Type:Plasticizer, Dioctyl Phthalate
- Usage:Plastic Auxiliary Agents, Textile Auxiliary Agents
- MOQ:200kgs
- Package:200kgs/battle
- Model:Dop Oil For Pvc
- Storage:Dry Place
India’s Department of Pharmaceuticals (DoP), which is the administrative department responsible for the formulation and implementation of policies relating to drugs
Uniform Code for Marketing Practices in Medical Devices 2024. On March 12, 2024, the Department of Pharmaceuticals ("DoP") introduced the Uniform Code for
Nishith Desai Associates Year End Regulatory Update 2023
- Classification:Chemical Auxiliary Agent
- CAS No.:117-84-0
- Other Names:DOP
- MF:C24H38O4
- EINECS No.:201-557-4
- Purity:99.9%
- Type:Plastic Auxiliary, Dop Plasticizer For Pvc
- Usage:Plastic Auxiliary Agents
- MOQ:200kgs
- Package:200kgs/battle
- Shape:Powder
The DoP, under the Ministry of Chemicals and Fertilizers, released the Approach aper on Draft National Pharmaceuticals Policy 2023 4 ("Approach Paper") on October 31,
New Delhi: The Department of Pharmaceuticals (DoP) has released the operational guidelines for the newly launched Strengthening of Medical Device Industry
India The National Medical Devices Policy, 2023: A Closer
- Classification:Chemical Auxiliary Agent
- CAS No.:117-84-0
- Other Names:DOP, diocty phthalate, 1,2-phthalate
- MF:C24H38O4, C24H38O4
- EINECS No.:201-557-4
- Purity:99.0%Min
- Type:Plasticizer Colorless Oily Liquid DOP for pvc and rubber
- Usage:PVC shoe, PVC Air Blowing/Expander PVC/DIP Shoes
- MOQ:200kgs
- Package:200kgs/battle
- Advantage:Stable
- Payment:T/T
In an earlier blog post, we took a close look at the National Medical Devices Policy, 2023 (“Policy”), notified by the Department of Pharmaceuticals (“DoP”) on May 2,
The Department of Pharmaceuticals (DoP) has submitted to the Cabinet Secretariat the final cabinet note on the National Policy on Research and Innovation in the Pharma
Press Release:Press Information Bureau
- Classification:Chemical Auxiliary Agent
- CAS No.:117-84-0
- Other Names:DOP/Dioctyl Phthalate
- MF:C6H4(COOC8H17)2
- EINECS No.:201-557-4
- Purity:99 %
- Type:Oil drilling
- Usage:Plastic Auxiliary Agents
- MOQ::10 Tons
- Package:25kg/drum
- Place of Origin::China
The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers has released on its website, an Approach Paper for the Draft National Policy for the Medical
, updated the Guidelines for the Production Linked Incentive Scheme ("PLI Scheme") 10 to revise the provisions concerning
- What is DOP approach paper 2022?
- The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers has released on its website, an Approach Paper for the Draft National Policy for the Medical Devices, 2022, inviting feedback and remarks of the Industry and stakeholders, till the 25th of March 2022.
- What are the major achievements of India's pharmacology department this year?
- Major achievements of the Department this year include schemes like 'Pradhan Mantri Bhartiya Janaushadhi Pariyojana' to provide quality generic medicines at affordable prices to the poor and underprivileged and PLI scheme to strengthen India's manufacturing capacity in the pharmaceutical sector by increasing investment and production.
- What is PLI scheme for pharmaceuticals in 2021?
- Under the Atmanirbharta initiative of the Government, Department of Pharmaceuticals launched the PLI scheme for pharmaceuticals in 2021. The financial outlay under this PLI scheme is Rs.15,000 Cr over a period of six years. So far, 55 applicants have been selected under the scheme, including 20 Micro, Small & Medium Enterprises (MSMEs).
- How has government aided the growth of medical devices in India?
- The Strategy Document highlights that this growth has been aided by government initiatives, including inter alia ‘Promotion of Medical Device Parks’ Scheme, 2020, ‘Production Linked Incentive Scheme for Medical Devices’, 2020, and ‘Public Procurement (Preference to Make in India)’ Policy, 2017.
- What is PLI scheme for bulk drugs?
- Under the PLI scheme for Bulk Drugs with a financial outlay of Rs.6940 Cr, the objective is to boost domestic production of 41 select critical bulk drugs in the country. So far, 51 projects have been selected for the 34 notified bulk drugs.
- How many applications have been registered under sub-scheme pharmaceutical technology upgradation assistance scheme (ptuas)?
- Under Sub-Scheme Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) more than 60 applications have been registered. The Scheme was approved with the objective of attaining self-reliance and reducing import dependence in critical KSMs/DIs/APIs.
